Trial Profile
To compare the efficacy and safety of dry powder inhaler of formoterol/glycopyrronium with dry powder inhaler of formoterol/budesonide in fixed dose combination in patients of chronic obstructive pulmonary disease(COPD)
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Nov 2018
Price :
$35
*
At a glance
- Drugs Formoterol/glycopyrrolate (Primary) ; Budesonide/formoterol
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 13 Nov 2018 New trial record